首页> 美国卫生研究院文献>Springer Open Choice >Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus

【2h】

Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus

机译：瑞舒伐他汀和非诺贝酸联合2型糖尿病患者血脂指标的实现

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveThe objective of this study was to assess the proportion of patients with type 2 diabetes mellitus (T2DM) attaining individual and combined targets of low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG), non-HDL-C, and apolipoprotein B (ApoB) after treatment with rosuvastatin (R) + fenofibric acid (FA) compared with corresponding-dose R monotherapy.

机译：目的本研究的目的是评估达到低密度脂蛋白胆固醇（LDL-C），高密度脂蛋白胆固醇（HDL-C），甘油三酸酯（个别）和合并目标的2型糖尿病（T2DM）患者的比例与相应剂量的R单药治疗相比，用瑞舒伐他汀（R）+非诺贝特酸（FA）治疗后的TG），非HDL-C和载脂蛋白B（ApoB）。

著录项

期刊名称 Springer Open Choice
作者
Robert S. Rosenson; Dawn M. Carlson; Maureen T. Kelly; Carolyn M. Setze; Boaz Hirshberg; James C. Stolzenbach; Laura A. Williams;
展开▼
作者单位

展开▼
年(卷),期 -1(25),1
年度 -1
页码 47–57
总页数 11
原文格式 PDF
正文语种
中图分类外科学;
关键词

相似文献

外文文献
中文文献
专利

1. Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus. [J] . Rosenson RS, Carlson DM, Kelly MT, Cardiovascular drugs and therapy . 2011,第1期

机译：瑞舒伐他汀和非诺贝特酸的组合在2型糖尿病患者中实现脂质靶点。
2. Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus [J] . Robert S. Rosenson, Dawn M. Carlson, Maureen T. Kelly, Cardiovascular Drugs and Therapy . 2011,第1期

机译：瑞舒伐他汀和非诺贝酸联合2型糖尿病患者血脂指标的实现
3. Attainment of goal/desirable lipid levels in patients with mixed dyslipidemia after 12 weeks of treatment with fenofibric acid and rosuvastatin combination therapy: A pooled analysis of controlled studies [J] . RothE.M., RosensonR.S., JonesP.H., Journal of clinical lipidology . 2012,第6期

机译：非诺贝特酸和瑞舒伐他汀联合疗法治疗12周后混合血脂异常患者达到目标/理想脂质水平：对照研究的汇总分析
4. Comparison of the effects of rosuvastatin and atorvastatin on plasma lipids and cytokines in hyperlipidemic patients with type 2 Diabetes [C] . Yoshino G., Osonoi T., Saitou M International Congress on Coronary Artery Disease . 2011

机译：枸杞子和阿托伐他汀对2型糖尿病患者血浆脂质和细胞因子的影响的比较
5. Effects of dietary unsaturated fatty acids on postprandial lipemia, antioxidant status and endothelial function in individuals with type 2 diabetes (non-insulin dependent diabetes mellitus). [D] . Hecker, Kari Dawn. 2003

机译：饮食中不饱和脂肪酸对2型糖尿病（非胰岛素依赖型糖尿病）个体餐后血脂，抗氧化状态和内皮功能的影响。
6. Response: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582–9) [O] . You-Cheol Hwang 2019

机译：响应：罗苏伐他汀单药20 mg瑞舒伐他汀5 mg和依泽替米贝10 mg联合治疗对2型糖尿病患者血脂参数的疗效比较（Diabetes Metab J 2019; 43：582–9）
7. Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus [O] . 2011

机译：瑞舒伐他汀与非诺贝特酸联合用于2型糖尿病患者血脂指标的实现

Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus

摘要

著录项

相似文献

相关主题

期刊订阅